UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uterine Microbiota: Residents, Tourists, or Invaders?

Frontiers in immunology, 2018-03, Vol.9, p.208-208

2018

Volltextzugriff (PDF)

Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women

Scientific reports, 2018-05, Vol.8 (1), p.7593-13, Article 7593

2018

Volltextzugriff (PDF)

Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment

PLoS computational biology, 2022-02, Vol.18 (2), p.e1009876-e1009876

2022

Volltextzugriff (PDF)

Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis

Scientific reports, 2019-05, Vol.9 (1), p.7333, Article 7333

2019

Volltextzugriff (PDF)

The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis

BMC women's health, 2024-03, Vol.24 (1), p.179-179, Article 179

2024

Volltextzugriff (PDF)

Hereditary predisposition to ovarian cancer, looking beyond BRCA1 / BRCA2

Gynecologic oncology, 2015-04, Vol.137 (1), p.86-92

2015

Volltextzugriff (PDF)

Radiation Therapy in Mismatch Repair-Proficient Patients With Isolated Nodal Recurrence

International journal of radiation oncology, biology, physics, 2024-02, Vol.118 (2), p.320-320

Chase, Dana M

2024

Volltextzugriff (PDF)

Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia

Virology (New York, N.Y.), 2014-01, Vol.448, p.314-321

2014

Volltextzugriff (PDF)

Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report

International journal of gynecological pathology, 2020-03, Vol.39 (2), p.152-156

2020

Volltextzugriff (PDF)

The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years

Frontiers in oncology, 2016-03, Vol.6, p.63-63

2016

Volltextzugriff (PDF)

Prescribers and patients drive maintenance therapy patterns in a community oncology practice: National guidelines versus the real-world experience

Gynecologic oncology reports, 2024-08, Vol.54, p.101440, Article 101440

2024

Volltextzugriff (PDF)

Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition

mSystems, 2022-04, Vol.7 (2), p.e0006422-e0006422

2022

Volltextzugriff (PDF)

Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study

Oncology and therapy, 2024-09, Vol.12 (3), p.599-607

2024

Volltextzugriff (PDF)

Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimens

Current opinion in obstetrics & gynecology, 2024-02, Vol.36 (1), p.1-8

2024

Volltextzugriff (PDF)

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158

2023

Volltextzugriff (PDF)

Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting

Gynecologic oncology reports, 2024-02, Vol.51, p.101332-101332, Article 101332

2024

Volltextzugriff (PDF)

Colposcopy to evaluate abnormal cervical cytology in 2008

American journal of obstetrics and gynecology, 2009-05, Vol.200 (5), p.472-480

2009

Volltextzugriff (PDF)

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211261-17588359221126149

2022

Volltextzugriff (PDF)

The development and use of vascular targeted therapy in ovarian cancer

Gynecologic oncology, 2017-05, Vol.145 (2), p.393-406

2017

Volltextzugriff (PDF)

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-05, Vol.125 (2), p.315-319

2012

Volltextzugriff (PDF)

Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling

EBioMedicine, 2019-06, Vol.44, p.675-690

2019

Volltextzugriff (PDF)

Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review

International journal of gynecological cancer, 2023-10, Vol.33 (10), p.1602-1611

2023

Volltextzugriff (PDF)

Health care services utilization in patients with ovarian cancer receiving PARP inhibitor maintenance treatment in a US community oncology setting

Gynecologic oncology, 2024-01, Vol.180, p.79-85

2024

Volltextzugriff (PDF)

Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay

Gynecologic oncology, 2021-06, Vol.161 (3), p.832-837

2021

Volltextzugriff (PDF)

A clinical pathway for postoperative management and early patient discharge: does it work in gynecologic oncology?

American journal of obstetrics and gynecology, 2008-11, Vol.199 (5), p.541.e1-541.e7

2008

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(66)
Humans
(56)
Female
(52)
Oncology
(40)
Obstetrics & Gynecology
(33)
Ovarian Cancer
(25)
Middle Aged
(24)
Adult
(22)
Aged
(19)
Quality Of Life
(18)
Chemotherapy
(17)
Cervical Cancer
(15)
Obstetrics And Gynecology
(15)
Cancer Therapies
(12)
Ovarian Neoplasms - Drug Therapy
(12)
Hematology, Oncology And Palliative Medicine
(11)
Retrospective Studies
(11)
Aged, 80 And Over
(10)
Cancer
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Uterine Microbiota: Residents, Tourists, or Invaders?

Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women

Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment

Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis

The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis

Hereditary predisposition to ovarian cancer, looking beyond BRCA1 / BRCA2

Radiation Therapy in Mismatch Repair-Proficient Patients With Isolated Nodal Recurrence

Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia

Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report

The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years

Prescribers and patients drive maintenance therapy patterns in a community oncology practice: National guidelines versus the real-world experience

Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition

Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study

Latest advances in immuno-oncology for endometrial cancer: single-agent and combination regimens

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting

Colposcopy to evaluate abnormal cervical cytology in 2008

Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial

The development and use of vascular targeted therapy in ovarian cancer

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling

Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review

Health care services utilization in patients with ovarian cancer receiving PARP inhibitor maintenance treatment in a US community oncology setting

Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay

A clinical pathway for postoperative management and early patient discharge: does it work in gynecologic oncology?

Suchergebnisse filtern